Summary:
Individuals who are already on a GLP-1 injection for 3 months or more may qualify for a trial comparing injectable GLP-1s with a once-daily oral weight loss pill. Individuals enrolled in this trial will either stay on their existing GLP-1 medication or be switched to the study medication; there is no placebo in this study. This trial is approximately 5 months long with up to 13 in-office visits and no overnight stays. Individuals in the trial may receive study-provided meal home deliveries, reimbursement of their GLP-1 during the trial and up to 12 months after completion of the trial, and compensation for their time at each completed visit.
Qualified Participants Must:
• 18 to 79 years old
• on GLP-1 injections for 3 months or more
Qualified Participants May Receive:
Individuals in the trial may receive study-provided meal home deliveries, reimbursement of their GLP-1 during the trial and up to 12 months after completion of the trial, and compensation for their time at each completed visit.